Skip to main content
logo
Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
1.080
-0.020 (-1.82%)
At close: Aug 21, 2026, 4:00 PM EDT
1.050
-0.030 (-2.78%)
After-hours: Aug 21, 2026, 7:59 PM EDT

Propanc Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
24800--
Market Cap Growth
-95.62%11552.55%2.31%---
Enterprise Value
34911--
Last Close Price
1.08103.751871.26202095.815250000.0073857142.86

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PB Ratio
0.103.47-0.11-0.13--
P/TBV Ratio
0.253.47----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Debt / Equity Ratio
0.050.12-0.25-0.17-0.34-0.22
Net Debt / Equity Ratio
0.010.12-0.24-0.17-0.34-0.22
Net Debt / EBITDA Ratio
-0.01-0.03-0.60-0.30-0.52-0.37
Net Debt / FCF Ratio
-0.03-4.23-0.99-0.48-0.72-0.59
Quick Ratio
0.130.000.010.000.000.00
Current Ratio
2.371.500.010.010.010.00
Return on Equity (ROE)
-126.98%-1163.67%----
Return on Assets (ROA)
-62.31%-363.36%-1447.01%-1564.19%-2626.42%-2029.40%
Return on Capital Employed (ROCE)
-169.20%-407.60%41.30%57.30%66.80%59.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-784.07%-122.28%-440.22%-658.24%--
FCF Yield
-169.78%-0.84%-226.12%-273.45%--